Marker Therapeutics, Inc. (MRKR) stock
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.85+0.02 (+1.98%)
Close on Nov 18, 2026Market cap $14.23MP/E –Yield –
Marker Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Marker Therapeutics's revenue for the twelve months ending Mar 31, 2026 was $3.95M, down 30.7% year over year. For fiscal 2025 it was $3.55M, down 46.2% from the year before. The highest annual figure on record is $6.59M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.55M | -46.2% |
| FY2024 | Dec 31, 2024 | $6.59M | +99.1% |
| FY2023 | Dec 31, 2023 | $3.31M | -5.8% |
| FY2022 | Dec 31, 2022 | $3.51M | +183.0% |
| FY2021 | Dec 31, 2021 | $1.24M | +148.3% |
| FY2020 | Dec 31, 2020 | $500.00K | +134.5% |
| FY2019 | Dec 31, 2019 | $213.19K | +3.5% |
| FY2018 | Dec 31, 2018 | $205.99K | +12.5% |
| FY2017 | Dec 31, 2017 | $183.06K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | $751.69K | +115.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.10M | -51.0% |
| Q3 FY2025 | Sep 30, 2025 | $1.23M | -36.0% |
| Q2 FY2025 | Jun 30, 2025 | $861.18K | -26.3% |
| Q1 FY2025 | Mar 31, 2025 | $349.10K | -71.9% |
| Q4 FY2024 | Dec 31, 2024 | $2.25M | +113.1% |
| Q3 FY2024 | Sep 30, 2024 | $1.93M | +647.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.17M | +53.3% |
| Q1 FY2024 | Mar 31, 2024 | $1.24M | +0.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.06M | +39.2% |
| Q3 FY2023 | Sep 30, 2023 | $257.61K | -74.2% |
| Q2 FY2023 | Jun 30, 2023 | $762.66K | -3.5% |
| Q1 FY2023 | Mar 31, 2023 | $1.23M | +28.0% |
| Q4 FY2022 | Dec 31, 2022 | $759.14K | +2185.5% |
| Q3 FY2022 | Sep 30, 2022 | $999.57K | – |
| Q2 FY2022 | Jun 30, 2022 | $790.51K | +69.4% |
| Q1 FY2022 | Mar 31, 2022 | $964.32K | +352.3% |
| Q4 FY2020 | Dec 31, 2020 | $33.22K | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $466.79K | +126.6% |
| Q4 FY2019 | Dec 31, 2019 | $213.19K | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | -100.0% |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q2 FY2018 | Jun 30, 2018 | $205.99K | – |
| Q4 FY2017 | Dec 31, 2017 | $0 | – |
| Q3 FY2017 | Sep 30, 2017 | $183.06K | – |
| Q2 FY2017 | Jun 30, 2017 | $0 | – |
See a number that looks wrong?